Abstract

IntroductionSystemic nutrition and inflammation are the critical factors in cancer initiation, evolution, and progression. This study aimed to evaluate the prognostic value of the prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) in hepatocellular carcinoma (HCC) patients who underwent liver resection. MethodsA total of 202 HCC patients met the criteria and were included in the study. The receiver operating characteristic (ROC) curve was used to calculate the optimal PNI and SII cutoff values. The relationship between PNI/SII and clinicopathologic parameters was analyzed. The effect of PNI and SII on recurrence-free survival (RFS) and overall survival (OS) was investigated by Kaplan-Meier curves and Cox proportional hazards models. ResultsThe areas under the ROC curve for PNI and SII were 0.64 and 0.58. The ideal preoperative PNI and SII cutoff values were 50.25 and 461.5, respectively. Multivariate Cox regression analysis identified that the PNI (P = 0.001) and tumor diameter (P = 0.018) were significant prognostic markers for RFS, and that the PNI (P = 0.049), SII (P = 0.039) and tumor diameter (P = 0.001) were significant prognostic markers for OS. The median RFS in the PNI-low and PNI-high groups was 13.5 months and 23 months (P = 0.001), and that in the SII-low and SII-high groups was 18 months and 15 months (P = 0.03), respectively. The median OS in the PNI-low and PNI-high groups was 24 months and 39 months (P = 0.001), and that in the SII-low and SII-high groups was 36 months and 22 months (P = 0.002), respectively. ConclusionInterestingly, we found that PNI and SII could be important prognostic parameters for HCC patients who under hepatectomy.

Highlights

  • Systemic nutrition and inflammation are the critical factors in cancer initiation, evolution, and progression

  • We found that prognostic nutritional index (PNI) (HR = 0.11; 95% confidence interval (CI) = 0.03–0.39; P = 0.001) and tumor diameter (HR = 1.27; 95% CI = 1.04–1.54; P = 0.018) were significant prognostic markers for recurrence-free survival (RFS), and that PNI (HR = 0.43; 95% CI = 0.19–1.00; P = 0.049), systemic immune-inflammation index (SII) (HR = 1.98; 95% CI = 1.04–3.77; P = 0.039), and tumor diameter (HR = 1.20; 95% CI = 1.08–1.33; P = 0.001) were significant prognostic markers for overall survival (OS) (Table 2)

  • We interestingly found that PNI and SII can predict the hepatocellular carcinoma (HCC) prognosis in patients who had underwent liver resection, and PNI and SII were independent risk factors for the OS of HCC patients

Read more

Summary

Introduction

Systemic nutrition and inflammation are the critical factors in cancer initiation, evolution, and progression. This study aimed to evaluate the prognostic value of the prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) in hepatocellular carcinoma (HCC) patients who underwent liver resection. Methods A total of 202 HCC patients met the criteria and were included in the study. The receiver operating characteristic (ROC) curve was used to calculate the optimal PNI and SII cutoff values. The effect of PNI and SII on recurrence-free survival (RFS) and overall survival (OS) was investigated by Kaplan-Meier curves and Cox proportional hazards models. Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system and has high morbidity and mortality worldwide. Liver transplantation, and radiofrequency ablation are the first-line radical treatments for HCC.[4, 5] For HCC patients, especially those with advanced-stage HCC, who are not candidates for radical treatments, locoregional therapies,[6] targeted

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call